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E-mail address: swt@stanford.edu (S.W. Tu).Formalizing eligibility criteria in a computer-interpretable language would facilitate eligibility determi-
nation for study subjects and the identiﬁcation of studies on similar patient populations. Because such
formalization is extremely labor intensive, we transform the problem from one of fully capturing the
semantics of criteria directly in a formal expression language to one of annotating free-text criteria in
a format called ERGO annotation. The annotation can be done manually, or it can be partially automated
using natural-language processing techniques. We evaluated our approach in three ways. First, we
assessed the extent to which ERGO annotations capture the semantics of 1000 eligibility criteria ran-
domly drawn from ClinicalTrials.gov. Second, we demonstrated the practicality of the annotation process
in a feasibility study. Finally, we demonstrate the computability of ERGO annotation by using it to (1)
structure a library of eligibility criteria, (2) search for studies enrolling speciﬁed study populations,
and (3) screen patients for potential eligibility for a study. We therefore demonstrate a new and practical
method for incrementally capturing the semantics of free-text eligibility criteria into computable form.
 2010 Elsevier Inc. All rights reserved.1. Introduction
Human studies are the most important source of evidence for
advancing our understanding of health, diseases, and treatment
options. It is therefore crucial to optimize the design, execution,
and use of human studies. Yet the current practices are fraught
with problems. Clinical trials have difﬁculty recruiting study sub-
jects. For example, a recent study in UK found that less than one
third of trials in a cohort of studies recruited their original target
within the time originally speciﬁed and 45% of the trials recruited
below 80% of their original recruitment target [1]. At the point of
care, clinicians are inundated with study results that relate only
partially to their patients [2]. Both problems would be ameliorated
by making computer-interpretable the eligibility criteria which de-
ﬁne the target populations of studies. At the design stage, study
investigators could query a library of computable criteria to help
deﬁne their study population by comparing the content and selec-
tivity of their criteria to those of related studies. At the execution
stage, investigators could query electronic health records to ﬁnd
potentially eligible subjects. Finally, at the usage stage, providersll rights reserved.
Campus Drive, Stanford, CAat the point of care could query for studies that enrolled patients
similar to theirs.
Formalizing eligibility criteria in a computer-interpretable lan-
guage, however, is an extremely labor-intensive task that requires
knowledge of the detailed syntax and semantics of the representa-
tional language [3]. In this paper, we brieﬂy discuss current ap-
proaches to creating computer-interpretable languages for
eligibility criteria (Section 2), the use cases and research questions
that motivate this work (Section 3), and the insights that led to the
newmethodology described in this paper (Section 4). This method-
ology aims at incrementally capturing the semantics of eligibility
criteria by deﬁning a representation intermediate in expressive-
ness between domain-speciﬁc enumerative criteria and expression
languages. This intermediate representation, called ERGO annota-
tion, is informed by both the complexity of natural language and
the requirements for computability. (ERGO annotation is based
on the eligibility rule grammar and ontology (ERGO) previously de-
ﬁned in The Trial Bank Project.1) We deﬁne ERGO annotations for
classes of eligibility criteria based on their logical and comparative
structure and on their noun phrases. This intermediate representa-
tion allows the encoding of free-text criteria to be partially auto-1 http://rctbank.ucsf.edu.
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and other computational methods. From ERGO annotations we gen-
erate computable expressions, such as OWL DL queries [4] or SQL
queries, that can be used to satisfy valuable use cases (Section 3).
We validate the methodology through detailed examples (Section
6) and through two preliminary evaluations that (1) demonstrate
the practicality of the encoding process using NLP methods, and
(2) assess the extent to which ERGO annotations capture the seman-
tics of sample eligibility criteria (Section 7).
2. Background
Currently, eligibility criteria are available only in free text that
are difﬁcult to parse or process computationally. As a consequence,
study repositories such as ClinicalTrials.gov generally ignore eligi-
bility criteria and use instead some notion of ‘‘health condition
studied” as the primary proxy for a study’s target population. This
approach is frequently inaccurate and does not allow for very spe-
ciﬁc searches. For example, searching ClinicalTrials.gov for studies
on ‘‘small cell lung cancer” returns 443 trials.2 If one were inter-
ested only in studies in ‘‘small cell lung cancer” patients with exist-
ing ‘‘brain metastases,” entering these terms into the basic search
ﬁeld returns 12 studies, of which only 3 require the presence of
brain metastases, while ﬁve studies are on preventing brain metas-
tases (i.e., patients with brain metastases are speciﬁcally ex-
cluded). The advanced search also has errors. Entering these
terms into the targeted search ﬁelds for conditions and specifying
NOT ‘‘brain metastases” in the outcomes ﬁeld returns 3 studies, but
only 2 of the 3 require brain metastases and erroneously including
1 study on preventing brain metastases in patients without brain
metastases. None of the other public trial registers (e.g., WHO,3
ISRCTN4) support targeted searches on eligibility criteria either,
but even if they did, simple keyword searches of the criteria text
would not be sufﬁcient, for reasons we discuss extensively in this pa-
per. If the eligibility criteria were computable, however, one could
search for studies enrolling patients with speciﬁc clinical features
such as prior chemotherapy or radiotherapy, or the extent and loca-
tion of metastases. Such clinically speciﬁc searches are needed to
more accurately ﬁnd studies for patients to enroll in, or to ﬁnd com-
pleted studies on patients similar to a given patient for whom clin-
ical trial evidence is being sought.
Over the years, informatics researchers have developed repre-
sentations of eligibility criteria. Some, like the ASPIRE project [5],
seek to develop consensus on a core coded set of generic (e.g.,
age, gender) and disease-speciﬁc (e.g., breast cancer stage, estrogen
and progesterone status) data elements for representing eligibility
criteria. Each data element has an associated value set that deﬁnes
its legal values (e.g., {Male, Female} for the Sex data element).
Other computable representations of eligibility criteria, like Arden
Syntax [6], GELLO [7], and other database or logic-based rule lan-
guages, employ domain-independent formal syntax for encoding
computer-interpretable expressions that use external terminology
systems. In Arden Syntax, the eligibility criteria of a study may be
deﬁned as a medical logic module (MLM) that includes speciﬁca-
tions for the events that trigger the MLM, the data needed to eval-
uate eligibility, the decision logic that computes an eligibility
status, and actions for alerting providers or patients. In GELLO, for-
malizing an eligibility criterion involves (1) specifying a patient
data model and codes from external terminologies, and (2) writing
the criterion using a formal object-oriented expression grammar.
In a rule language such as JESS,5 eligibility criteria can be encoded2 Search performed on June 27, 2010.
3 http://apps.who.int/trialsearch/.
4 http://www.controlled-trials.com/isrctn/.
5 http://www.jessrules.com/.either as individual rules, or as declarative data structures that are
evaluated using generic rules. Similarly, eligibility criteria can be
written directly as SQL queries for some relational databases.
Encoding eligibility criteria into existing representations pre-
sents a number of problems. ASIPRE’s domain-speciﬁc coded eligi-
bility criteria have not been fully standardized, and it will take
years to create eligibility codes for all disease areas. This enumer-
ative approach does not make use of existing reference terminolo-
gies. Thus, for example, it would represent ‘‘Presence of asthma”
and ‘‘Presence of severe asthma” as two criteria whose relationship
to each other cannot be inferred from ‘‘Asthma” (SNOMEDCT
195967001) and ‘‘Severe Asthma” (SNOMEDCT 370221004) in a
standard terminology. Furthermore, having no mapping of ASPIRE
elements to patient data models and terminologies, ASPIRE criteria
cannot be used directly for eligibility screening using existing EHR
data.
Computable expression languages such as Arden Syntax, GELLO,
SQL, and rule languages combine the use of domain-independent
generative syntax with standard terminologies and data models.
However, they are designed primarily for providing patient-spe-
ciﬁc decision support in clinical information systems. They provide
no method for classifying or reasoning with formalized eligibility
criteria. Like ASPIRE, Arden Syntax and GELLO offer no way to iden-
tify a relationship between the criterion expressions for ‘‘Presence
of Asthma” and ‘‘Presence of severe asthma.” In Arden Syntax, que-
ries for such data would be hidden in the institution-speciﬁc ‘‘curly
braces” [8]. In GELLO and other rule and database languages, on the
other hand, encoding eligibility criteria requires a commitment to
a speciﬁc patient data model. For example, to encode in GELLO a
simple criterion such as ‘‘Presence of azotemia within the last
3 months” would require that the criterion be written in terms of
some data structure (e.g., Observation) that has a code for azote-
mia, and a time stamp for the observation. The criterion could be
represented as shown in Fig. 1.
Commitment to a patient data model is necessary for linking
criteria with patient data for screening purposes, but it poses sev-
eral problems. It limits the possibility of using the encoded criteria
for multiple use cases, as is desired for eligibility criteria (Section
3). Furthermore, it complicates the encoding process. Not only does
the encoder need to know the syntax and semantics of a complex
language like Arden Syntax or GELLO, she also needs to make
assumptions about how patient data are represented. This com-
plexity adds to the difﬁculty and labor demands of formalizing eli-
gibility criteria.
Another weakness of expression languages like GELLO and Ar-
den Syntax is that they do not support encoding of the noun
phrases which contain much of the semantics of free-text criteria.
Having been designed for matching criteria with patient data,
those languages typically assume that potentially complex noun
phrases in eligibility criteria (e.g., ‘‘Histologically or cytologically
conﬁrmed extensive stage small cell lung cancer”) can be repre-
sented using a single terminological code.
To overcome some of these shortcomings, we previously cre-
ated ERGO, a template-based expression language that can capture
the full expressivity of eligibility criteria from any clinical domain
[9]. Like GELLO, ERGO is based on an object-oriented data model,
and its expressions can be seen as a subset of GELLO, except that:
(1) Instead of being a string-based language, ERGO expressions
are largely (though not completely) deﬁned by a set of
frame-based templates;
(2) ERGO allows not only Boolean combinations of statements,
but also statements linked by semantic connectors such as
deﬁned by (e.g., ‘‘adult patients deﬁned by age >= 18 years”)
and by examples (e.g., ‘‘Planned coronary revascularization
such as stent placement OR heart bypass”);
Fig. 1. The GELLO expression language assumes a patient data model that may includes an Observation class that has properties ‘effectiveTime’ (an interval with high and low
limits), ‘code’ consisting of a coded concept (e.g., terminology and code), and ‘value’ that may be a coded concept or a physical quantity that has a value and unit.
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tionships, such as ‘‘occurrence of a stroke within six months
following a myocardial infarction”; and
(4) ERGO explicitly models terminological expressions as part of
the language.
In ERGO, clinical statements are built from other clinical state-
ments and from expressions that can be data values (e.g., physical
quantities, time points and time intervals as well as standard prim-
itive data types), functions, queries, variables, and noun phrases.
ERGO deﬁnes three subclasses of noun phrases:
(1) Primitive noun phrases (e.g., ‘‘myocardial infarction”), which
represent terms from vocabularies.
(2) Logical combinations of noun phrases connected by and, or,
or not (e.g., ‘‘myocardial infarction or diabetes mellitus”).
The and, or, and not operators are interpreted as intersection,
union, and complement of the corresponding sets,
respectively.
(3) Noun phrases with modiﬁers that place restrictions on the
root noun phrase. Modiﬁers follow the entity–attribute-
value model (e.g., asthma induced by exercise). In cases
where the attribute of the modiﬁer is unclear, we use a
default modiﬁed_by attribute (e.g. ‘‘asthma modiﬁed_by
transient”).
We developed ERGO based on our past experiences in designing
template-based expression languages for encoding guideline-
based decision support knowledge [10,11]. While encoding eligi-
bility criteria using a template-based approach eliminates the need
to remember and follow the strict syntax of a string-based lan-
guage, it still requires a commitment to a patient data model and
is still a labor-intensive process that scales poorly to encoding
free-text criteria from tens of thousands of existing human studies.Table 1
Semantic complexity in eligibility criteria.
Criteria type
A Total criteria
B Comprehensible criteria
C Elementary criteria EC
D EC requiring clinical judgment
E EC dependent on study metadata for comprehensibility
F Compound criteria: CC (B–C)
G CC requiring clinical judgment
H CC dependent on study metadata for comprehensibility
I Overlap between G&H
J Informative criteria (B  D  E  G  H + I)
K Informative elementary criteria (C–D–E)
L Informative criteria with one or more negations
M Informative criteria with one or more arithmetic comparison op
N Informative criteria with one or more temporal comparison ope
O Informative criteria with one or more Boolean connectors
P Informative criteria with if–then statementsFor example, using ERGO to encode the criterion ‘‘most recent
white blood cell count > 4000/mm3” requires the instantiation of
templates for comparing an expression with a value, for querying
white blood cell count observations, and for selecting the most re-
cent observation in the query result. A more practical method for
encoding eligibility criteria is needed to optimize the design, exe-
cution, and use of human studies.
3. Research question and hypothesis
To address the problems inherent in existing methods for
encoding eligibility criteria, we hypothesized that we could create
a new method for encoding such criteria that uses an intermediate
representation
 which is midway in complexity between ASPIRE’s domain-spe-
ciﬁc enumerative criteria and expression languages such as
GELLO;
 whose encoding requires few specialized skills and can be par-
tially automated; and
 which will nevertheless help us satisfy the use cases for eligibil-
ity criteria. These use cases include (1) constructing a library of
eligibility criteria such that, for a given criterion, we can ﬁnd
more general or more speciﬁc criteria; (2) searching for studies
whose target population satisﬁes certain criteria; and (3)
screening an EHR database for patients potentially eligible for
a study.
The method begins with the free-text eligibility criteria of clin-
ical studies, incrementally classiﬁes the criteria into well-deﬁned
statement types, and annotates the criteria using this intermediate
representation. The representation allows us to support multiple
different use cases of value across the study lifecycle from design
to execution to application.Criteria number Proportion of informative criteria
1000
932
139
14
0
793
152
151
22
637
125 0.20
132 0.21
erators 112 0.18
rators 245 0.38
247 0.39
35 0.05
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The methods we report on in this paper were informed by a sep-
arate study we conducted to analyze the types and range of com-
plexity in eligibility criteria [12]. That study classiﬁed 1000
clinical trial eligibility criteria randomly selected from ClinicalTri-
als.gov according to their comprehensibility, semantic complexity,
and content variation (Table 1). Comprehensibility refers to the de-
gree to which a criterion has some discriminatory power – that is,
logic as an inclusion or exclusion criterion – which is readily appar-
ent to the average clinician. In that sample, 927/1000 criteria were
judged ‘‘comprehensible.” We then classiﬁed those comprehensi-
ble criteria by their semantic complexity, as either ‘‘elementary”
or ‘‘compound.” Elementary criteria consist of a single noun phrase
(e.g., ‘‘uncontrolled hypertension”) or its negation (‘‘not pregnant”),
or a simple quantitative comparison (e.g., WBC > 5000 cells/mm3).
All other criteria were deemed to be compound criteria. Table 1
shows various dimensions of content-based variation, whether
semantic (negation, Boolean connectors, arithmetic comparison
operators, temporal connectors and comparison operators, if–then
statements) or not (requiring clinical judgment, dependent on
metadata). Criteria that call for clinical judgment (e.g., ‘‘eligible
for statin therapy”) or that implicitly reference other metadata
about the study (e.g., ‘‘No evidence of metastases” where the type
of primary carcinoma is speciﬁed elsewhere in the study protocol)
are considered underspeciﬁed. Of the initial 1000 criteria analyzed,
a total of 632 criteria were informative in that they were compre-
hensible and required no clinical judgments or additional
metadata.
Based on the results of this study characterizing the complexity
of eligibility criteria, and on our prior experiences encoding eligi-
bility and decision criteria for guidelines and protocols, we ob-
served that
 Much of the operative semantics of eligibility criteria are cap-
tured in terminological expressions and comparison state-
ments. These ‘‘surface” semantics can support the three use
cases described in Section 3 without needing to capture 100%
of the meaning that is in the criteria. For example, ‘‘heart fail-
ure” by itself captures much of the meaning of ‘‘severe heart
failure.”
 Natural-language processing (NLP) techniques have been used
to extract coded concepts from narrative text with high recall
and precision [13,14].
 Computational methods such as description logic subsumption
reasoning can organize terminological expressions into classiﬁ-
cation hierarchies that we can use to index eligibility criteria.
We ﬁrst used the classiﬁcation of clinical statements and noun
phrases in ERGO to deﬁne ERGO annotations as an intermediate
representation that bridges the gap between natural language eli-
gibility criteria and fully speciﬁed ERGO criteria. Instead of trying
to capture all of the semantics of an eligibility criterion, an ERGO
annotation is essentially a terminological expression used to anno-
tate and index the criterion. The process of encoding free-text cri-
teria into ERGO annotations entails extracting appropriate noun
phrases and semantic connectors. This process can be partially
automated using NLP techniques. Along the way, the noun phrases
can be mapped to terms in standard terminologies and to UMLS
semantic types whenever possible.
We recognized that it would be very hard to automatically rec-
ognize noun phrases in the types of complex sentence fragments
that eligibility criteria are often written in. Therefore, in this
proof-of-concept work, we added pre-processing steps to semi-
structure the criteria. We evaluated our NLP encoding process to
demonstrate the practicality of a computer-assisted process forannotating eligibility criteria. We also analyzed the extent to which
ERGO annotations could capture the range of complexity and
semantics we identiﬁed in our eligibility criteria complexity study
(Table 1). Finally, using concrete examples, we clariﬁed how ERGO
annotations could be used with a description logic reasoner and a
relational database to satisfy the three use cases enumerated in
Section 3. We deﬁned algorithms for generating web ontology lan-
guage (OWL) [4] expressions and SQL queries, given speciﬁc
assumptions about terminologies and patient data models when
necessary.5. Method description
Our method for annotating eligibility criteria with ERGO anno-
tations has three components: (1) classiﬁcation of eligibility crite-
ria statement types and the deﬁnition of ERGO annotation for each
statement type; (2) an encoding process that involves ﬁrst re-writ-
ing eligibility criteria so that they fall into the criteria statement
types, using NLP techniques to extract concepts, modiﬁers, Boolean
connectives, other semantic connectors and comparison relation-
ships, and then generating ERGO annotations for each criterion;
(3) for each use case, depending on the application’s computational
environment, generating computable expressions from ERGO
annotations so that they can be applied in the use cases.5.1. Criteria classiﬁcation and ERGO annotation
Our team has extensive prior experience encoding decision cri-
teria in guidelines and protocols [11,15], and analyzing the types
and range of complexity in eligibility criteria [12]. Based on this
experience, we categorize eligibility criteria into three classes of
clinical statements that are mutually exclusive:
(1) Simple statements making a single assertion (e.g., ‘‘asthma
induced by exercise”). These may involve complex modiﬁers
and constraints (e.g., ‘‘Tuberculosis of intrathoracic lymph
nodes, conﬁrmed bacteriologically and histologically within
6 months”) or may be expressed at a high level of abstrac-
tion (e.g., ‘‘treated for LDL-C”).
(2) Comparison statements of the form Noun Phrase comparison
operator (e.g., >, < =) Quantity.
(3) Complex statements – that is, multiple statements joined by
Boolean connectives AND, OR, NOT, IMPLIES or semantic con-
nectors (e.g., evidenced by). The Boolean connectives are log-
ically deﬁned keywords, not linguistic terms that may be
used imprecisely. Ideally, the semantic connectors should
come from some controlled terminology.
For simple statements, we deﬁne a valid ERGO annotation as
the most speciﬁc noun phrase that can be extracted from the crite-
rion, or noun phrases that are either semantically equivalent to or
allowable generalizations of that most speciﬁc noun phrase. A
noun phrase may be post-coordinated with modiﬁers. For example,
themost speciﬁc ERGO annotation of the criterion ‘‘asthma induced
by exercise” is the UMLS code C00004096 (asthma) with the attri-
bute induced by and the attribute value C0015259 (exercise). Other
valid ERGO annotations include C0004099 (asthma, exercise-in-
duced), which is semantically equivalent to the most speciﬁc noun
phrase, or C00004096 (asthma), which is a generalization. We cate-
gorically exclude several types of generalizations from being valid
ERGO annotations. One is noun phrases (e.g., ‘‘disease” or ‘‘syn-
drome”) that are equivalent to high-level UMLS semantic types
and therefore are too general to be informative. We also exclude
noun phrases that cannot be meaningfully asserted about a person
(e.g., a person’s ‘‘pressure” is not a meaningful generalization of a
S.W. Tu et al. / Journal of Biomedical Informatics 44 (2011) 239–250 243person’s ‘‘high blood pressure”). Lastly, to be valid, generalizations
must preserve the core meaning of the criterion. We operationalize
this constraint by requiring ERGOannotations to be nomore general
than the root of a noun phrase. For example, if the criterion is ‘‘se-
vere asthma,” valid annotations include ‘‘severe asthma” and ‘‘asth-
ma,” but not ‘‘pulmonary problem.”
If a simple statement’s noun phrase is a logical combination of
other noun phrases, we deﬁne valid ERGO annotations for each
component noun phrase as discussed above, join the annotations
with the logical connectives, and then exclude any constructs that
are self-contradictory. For example, the ERGO annotations for
‘‘NOT severe asthma” include ‘‘NOT asthma” and ‘‘NOT severe asth-
ma” because both ‘‘asthma” and ‘‘severe asthma” are valid ERGO
annotations of ‘‘severe asthma.” If the criterion were ‘‘asthma
and NOT severe asthma,” however, ‘‘NOT asthma” cannot be a valid
ERGO annotation for ‘‘NOT severe asthma” even if ‘‘asthma” is valid
at the component level because the overall joined criterion will
then be ‘‘asthma AND (NOT asthma)” which is an unsatisﬁable log-
ical combination.
For comparison statements, a valid ERGO annotation is the trip-
let {noun phrase, comparison operator, quantity}, where quantity
may be a string when the quantity cannot be expressed as a value
and unit. Finally, for complex statements, we deﬁne valid ERGO
annotations to be the valid ERGO annotations of its component
simple and comparison statements joined by the relevant Boolean
and semantic connectors.
Fig. 2 shows examples of ERGO annotations for a simple state-
ment and a comparison statement in the Protégé tool.
5.2. Annotation process
The process of encoding ERGO annotation can be either com-
pletely manual or assisted by applying NLP techniques. Our current
semi-automated annotation method includes three stages: manual
pre-processing and re-writing, application of NLP to the rewritten
criteria, and ﬁnally the generation of ERGO annotations from the
NLP output.
Free-text eligibility criteria are often sentence fragments whose
meaning and complexity range from simple to highly complex. Be-
cause this work is only an initial feasibility study, we manually
pre-processed and rewrote raw eligibility criteria to yield more
tractable criteria for the automated process. Advances in NLP
may help to automate these steps in the future. We:
 Eliminated criteria or parts thereof that were too vague, were
purely explanatory (e.g., parenthetical contents in ‘‘Low HDL
cholesterol (‘good cholesterol’)),” or had no discriminating
power (e.g., ‘‘Men or women”, or criteria describing allowable
states, e.g., ‘‘Concurrent bisphosphonates allowed”).Fig. 2. ERGO annotations. (a) a simple statement annotation for a noun phrase composed
for an assessment of Framingham risk score greater than 0.2. Eliminated redundant words (e.g., ‘‘patients” in ‘‘adult
patients”).
 Separated ‘‘run-on” criteria into stand-alone criteria (e.g., ‘‘Sta-
ble CAD patients (men and post-menopausal women)” should
be ‘‘Stable CAD patients” and ‘‘men and post-menopausal
women”).
 Eliminated or rewrote criteria or parts thereof that speciﬁed
physician discretion for eligibility, resulting in either more or
less stringent criteria than the original. E.g., ‘‘History of a psy-
chological illness that interferes with the subject’s ability to
understand study requirements” becomes ‘‘History of a psycho-
logical illness”; or elimination of the entire exclusion criterion
‘‘Certain medications that may interfere with the study”.
After this pre-processing, the criteria were classiﬁed manually
as simple, comparison, or complex statements, and were then
rewritten by:
 Decomposing complex statements into simple and comparison
statements, by making implied semantics explicit if needed
(e.g., ‘‘adults, 18–75 years of age” is rewritten as ‘‘adults deﬁned
by (age >= 18 years AND age <= 75 years).
 Regularizing comparison statements so that the variable and its
value are on the left and right hand sides, respectively (e.g., ‘‘at
least 18 years old” becomes ‘‘age >= 18 years”; ‘‘WBC greater
than 13,000 or lower than 3000” becomes ‘‘WBC > 13,000 OR
WBC < 3000”)
 Making Boolean connections explicit (e.g., ‘‘CHD, including
patients with other CHD risk factors” is pre-processed to
‘‘CHD, including CHD risk factors” and then rewritten as ‘‘CHD
OR CHD risk factors”).
 Expanding acronyms (e.g., ‘‘CHD” becomes ‘‘coronary heart
disease”).
 Making diagnoses, conditions, and treatments explicit (e.g.,
‘‘Severe asthma that is poorly controlled with medication” is
rewritten as ‘‘Severe asthma AND poorly controlled asthma
AND taking asthma medication”).
 Re-writing partial lists (e.g., ‘‘treatment with drugs raising HDL
(e.g., niacin, ﬁbrates)” becomes ‘‘treatment with drugs raising
HDL OR treatment with niacin OR treatment with ﬁbrates”).
 Using implication as a logical connector where needed (e.g.,
‘‘Women must be post-menopausal or using effective birth con-
trol” is rewritten as ‘‘women IMPLIES (post-menopausal OR
using effective birth control)”).
 Re-writing terminological negation as EXCLUDING, to avoid con-
fusion with Boolean negation (e.g., ‘‘Any life-threatening disease
expected to result in death within 2 years (other than heart dis-
ease)” becomes ‘‘life-threatening disease EXCLUDING heart dis-
ease AND life expectancy <= 2 years”).of ﬁve terms combined together using OR; (b) a comparison statement annotation
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have been pre-processed, rewritten, and structured into simple,
comparison, and complex statements whose contents are still in
free text. Any number of biomedical concept extraction techniques
[13,14,16] can then be applied to parse or chunk the free text into
parse trees or segments that isolate the noun phrases and compar-
isons and that annotate the noun phrases with UMLS concept un-
ique identiﬁers (CUIs) when such annotations are available. To
convert this material into ERGO annotations, we deﬁned heuristic
algorithms that incorporate both linguistic and clinical heuristics
(details can be found online in Appendix 1). An example of a lin-
guistically based heuristic is that, in English, the root noun phrase
is usually the right-most noun phrase that is modiﬁed by adjectival
phrases occurring to its left. An example of a clinically based heu-
ristic is the following. If there is more than one noun phrase in a
criterion, the algorithm ﬁrst checks to see if they can be connected
by a terminological AND, OR, or excluding. If not, the algorithm
gives preference to noun phrases that have semantic types disease
or syndrome, clinical drug, procedure, and ﬁnding in that order. If
the noun phrases are not of the above semantic types or if the noun
phrases cannot be mapped to UMLS CUIs, we arbitrarily select the
left-most noun phrase as the ERGO annotation for the criterion.
The overall result of this pre-processing, re-writing, NLP process-
ing, and heuristic noun phrase identiﬁcation process can now be
instantiated as ERGO annotations either automatically or by a hu-
man coder.5.3. Use of ERGO annotations
Once the encoding process produces ERGO annotations for eligi-
bility criteria, they can be applied to the use cases described in Sec-
tion 3. The ﬁrst use case is constructing a library of eligibility
criteria such that a researcher can search for any given criterion,
and can ﬁnd more general or more speciﬁc criteria.5.3.1. Library of eligibility criteria
An information resource indexes its entries to facilitate search.
A library of eligibility criteria can use words in the criteria (with
appropriate ﬁltering of stop words) or terms derived from auto-
mated term-recognition for indexing purposes. If the recognized
terms come from a reference terminology, searching for criteria
in the library can make use of hierarchical relationships in the ter-
minology. However, the structure of ERGO annotations allows us to
create a classiﬁcation hierarchy of eligibility criteria that is much
more precise. We formulate ERGO annotations as fully deﬁned
description logic (DL) concepts that extend an existing reference
terminology (e.g., SNOMED [17]), from which a DL reasoner will
be able to automatically construct the needed hierarchies for
indexing eligibility criteria. Individual criteria and their ERGO
annotations will therefore be placed in the proper hierarchical
relationship to other more general or more specialized criteria in
the library.
To construct the eligibility criteria classiﬁcation hierarchy as a
hierarchy of DL expressions, we need to pick a preferred ERGO
annotation to index each criterion. For simple or comparison state-
ments, we can simply take the intersection of all valid ERGO anno-
tations as the preferred one (e.g., intersecting ‘‘Severe anemia” and
‘‘Anemia” yields ‘‘Severe anemia”, and intersecting ‘‘Severe ane-
mia” and ‘‘Chronic anemia” yields (‘‘Severe anemia and Chronic
anemia”). In this case, the preferred annotation is the most speciﬁc
annotation supported by the criterion.
For complex statements, the preferred ERGO annotation is con-
structed recursively by applying Boolean and semantic connectors
to the preferred ERGO annotations of the component statements.
For example, the preferred ERGO annotation of the criterion‘‘Elevated blood pressure deﬁned by systolic blood pressure
>140 mmHg and diastolic blood pressure >80 mmHg” is ‘‘Elevated
blood pressure” deﬁned_by {systolic blood pressure, ‘ > ’,
140 mm Hg} AND {diastolic blood pressure, ‘ > ’, 80 mm Hg}.
Using web ontology language (OWL) [4] as the DL language, we
show how to construct DL expressions from ERGO annotations. For
a simple statement, an ERGO annotation is essentially a noun
phrase that may have certain modiﬁers. A modiﬁer may have an
explicit attribute (e.g., ‘‘severity”) and an attribute value (e.g.,
‘‘severe”) or it may be an adjective with no explicit attribute, in
which case we use ‘‘modiﬁed_by” as the default attribute. A noun
phrase N with modiﬁer M can be written as the OWL expression
(using the Manchester syntax) (N and (modifier some M)), where
modifier is an OWL object property. A comparison statement can
be deﬁned in OWL 2.0 as restrictions on a noun phrase and a quan-
tity. ‘‘White blood cell count >5000/mm3,” for example, can be
written as (WhiteBloodCellCount and has_value some
(Physical_quantity and has_unit value ‘/mm3’ and
has_realvalue some real[>5000]), where WhiteBlood-
CellCount is a class representing white blood cell count measure-
ment and Physical_quantity is a class that has unit and real
number components. For complex statements, we treat the Bool-
ean connectors as OWL intersection, union, and set complement
operations and the semantic connector deﬁned_by as an OWL
equivalence relation. Other semantic connectors, such as evi-
denced_by or caused_by, become OWL object properties so that,
for example, ‘‘coronary heart disease evidenced by angiography”
becomes the OWL restriction ‘‘coronary_heart_disease AND
(evidenced_by some angiography).” This example shows that
if, for example, all eligibility criteria in ClinicalTrials.gov were
annotated with preferred ERGO annotations, the criteria could be
searched for hierarchically related criteria, to facilitate standardi-
zation and reuse of criteria.
5.3.2. Searching for studies enrolling speciﬁc patient populations
The second use case – searching for studies whose target popu-
lation satisﬁes certain criteria – can also be formulated as a classi-
ﬁcation problem. For any study, the conjunction of all inclusion
criteria and the negations of all exclusion criteria deﬁne the target
population. For each criterion, we can ﬁnd the preferred ERGO
annotation and formulate the associated OWL expression as de-
scribed above. The conjunction of the OWL expressions associated
with the inclusion criteria and the negation of the exclusion crite-
ria approximates the characteristics of the study’s target popula-
tion. A query for studies based on certain criteria (e.g., all studies
that include female subjects who are HIV positive and have viral
load below a certain threshold) can be resolved by ﬁnding all stud-
ies whose associated OWL expressions are more speciﬁc than the
query for all of the inclusion and negated exclusion criteria.
To perform a search for studies based on their eligibility criteria,
a user will construct query expressions consisting of a Boolean
combination of noun phrases and comparisons. Fig. 3a–c shows a
possible interface that allows a user to construct such queries
without having any knowledge of description logic or OWL.
5.3.3. Screening for potentially eligible participants
We could apply the same approach to the third use case –
screening an EHR database for potentially eligible patients – by
matching the OWL expressions as in the second use case to a
description logic characterization of the state of a patient. This ap-
proach, however, is unappealing for several reasons. First, when
the exclusion criteria are formulated as negated expressions, it is
difﬁcult to prove, with the open-world assumption of OWL, that
a patient satisﬁes those criteria without ﬁrst specifying explicit
closure axioms. Second, and more important, it is unrealistic to ex-
pect EHR data to be widely available as OWL expressions.
Fig. 3. (a) A possible user interface for specifying a conjunction of disjunctive
queries. Clicking on the ‘‘More” button refreshes the screen and creates a new set of
OR subqueries. The button allows the creation of a new comparison ERGO
annotation as shown in (b) or a new noun phrase ERGO annotation as shown in (c).
(c) A possible user-interface for specifying a noun phrase such as ‘‘Tuberculosis of
intrathoracic lymph nodes, conﬁrmed histologically,” initially consisting of a
primitive noun and its adjectival modiﬁers. By clicking on the ‘‘More” button, a
user can specify additional modiﬁer attributes and noun phrases. Tool support can
easily facilitate the task of searching terminological references such as primitive
nouns and adjectival modiﬁers.
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for use in relational database technology is preferred over using
OWL. Each institution will customize such translation of standard-
ized ERGO annotations according to the requirements of their EHR.
As we demonstrate in the following example, such translation can
be speciﬁed using mapping tables and generic mapping rules. Un-
like a variable in a medical logic module that is implemented using
an idiosyncratic curly brace, ERGO annotations can be translated
systematically. The expectation is that translation can be auto-
mated so that, as new studies are added to the library, their eligi-
bility criteria can receive standard annotation once, and multiple
institutions can translate them to use their institution-speciﬁc
EHR data. Informaticians will be involved in designing and imple-
menting the translation mechanism for the institution as a whole.
End users such as study coordinators should be able to download
the ERGO annotations and apply the automated translation to gen-
erate institution-speciﬁc queries.
To illustrate this through an example, we make certain assump-
tions to duplicate the features of a real example. First, we assume
an implementation of SQL and a certain patient data model. For
illustrative purposes, we chose Microsoft Access and a simple data
model for patient data keyed to the patient ID:
 DemographicsData table containing patient demographic data
(e.g., date of birth, gender) whose key is the patient ID;
 ProblemList table containing the problem name (e.g., disease
name), a code for the problem, and its start and end times; Medication table containing drug names and codes, the pre-
scribed dose and frequency for each drug, and prescription start
and end times;
 LaboratoryTestResult table containing test names and codes,
the values and units of test results, and the test dates;
 Assessment table containing computed or assessed results
rather than laboratory test results (e.g., the Framingham coro-
nary heart disease score), their codes, and the assessment dates.
We must also make assumptions regarding terminology. We as-
sumed that problems are speciﬁed as ICD-9 codes. In order to map
ICD-9 codes and drug codes to the UMLS terms used in the ERGO
annotations, we created a TerminologyMapping table which, for
each UMLS code, speciﬁed the possible EHR ICD-9 and drug codes
corresponding to a patient’s problems and medications.
A third assumption concerns the assignment of terms used in
the eligibility criteria to the appropriate tables in the patient data
model. We employed several rules for this task. For example, crite-
ria terms whose UMLS semantic type was disease or syndrome
were mapped to the ProblemList table, terms whose semantic type
was pharmacologic substance or clinical drug were mapped to the
medication table, and terms whose semantic type was laboratory
or test result were mapped to the LaboratoryTestResult table. For
speciﬁc noun phrases, such as age, gender, or sex, we used special
rules that mapped them to the DemographicData table. For exam-
ple, ‘‘age” had to be treated in a special way, because the informa-
tion in the patient data model was date of birth, which had to be
converted to age using SQL functions. We did not develop rules
for mapping terms into the assessment table.
We illustrate the process of creating SQL queries from the ERGO
annotations of a simple statement. For simple statements, the
ERGO annotation consists of a noun phrase built up from a primi-
tive noun phrase, its modiﬁers, and/or the conjunction, disjunction,
and complement of other noun phrases. A primitive noun phrase
has the properties preferred_name, code_system, and code.
For primitive noun phrases whose semantic types are disease or
syndrome, pharmacologic substance, or clinical drug, we created
an SQL query of the form:
 SELECT * FROM ProblemList, TerminologyMapping
 WHERE problem_code = EHR_code and and UMLS_code =
code);
where the TerminologyMapping table was used to map eligibility
criteria terms to patient data model terms that appear in the Prob-
lemList table.
For noun phrases made up of the conjunction and/or disjunction
of other noun phrases (AndOr_Noun_Phrases) whose semantic
types are disease or syndrome, pharmacologic substance, or clini-
cal drug, the WHERE part of the query repeats for all concepts
and modiﬁer terms of the AndOr_Noun_Phrases. (And or Or) is
translated into the corresponding SQL operator AND or OR. This re-
sulted in queries of the form:
 SELECT * FROM ProblemList, TerminologyMapping
 WHERE problem_code = EHR_code and UMLS_code =
concept1.code). . .
 (problem_code = EHR_code and UMLS_code = conceptn.code);
The online Appendix 2 contains details for generating SQL que-
ries from other types of ERGO annotations.
6. Validation through examples
We tested the feasibility and utility of capturing eligibility
criteria in ERGO annotation by re-writing a set of eligibility criteria
Table 2
Selected eligibility criteria after pre-processing and categorization as described in Section 5.2. ‘‘I” denotes inclusion criteria and ‘‘E” denotes exclusion criteria.
I/E Original text After pre-processing Classiﬁcation
I Adult patients, 18–75 years of age Adult, 18–75 years of age Complex
I CHD, including patients with other CHD risk factors CHD, including CHD risk factors Complex
E Previous exposure to any CETP inhibitor or vaccine Previous exposure to any CETP inhibitor or vaccine [no change] Complex
E Poorly controlled diabetes Poorly controlled diabetes [no change] Simple
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tions. In the following sections, we illustrate this process. We then
demonstrate the possibility of using ERGO annotations for the use
cases described in Section 3.
6.1. Examples of annotation process
6.1.1. Pre-processing the eligibility criteria
We entered the eligibility criteria from the selected trials (Sec-
tion 7.2) in an Excel spreadsheet and used it to record all applied
transformations: pre-processing, re-writing and breaking down
of complex statements into their constituent parts. To demonstrate
this, we use the trial with ClinicalTrials.gov id NCT 00655473,
which has inclusion criteria such as ‘‘adult patients, 18–75 years
of age” and ‘‘CHD, including patients with other CHD risk factors,”
and exclusion criteria such as ‘‘previous exposure to any CETP
inhibitor or vaccine” and ‘‘poorly controlled diabetes.”
We ﬁrst pre-processed and classiﬁed the criteria into simple,
comparison, and complex according to the steps described in Sec-
tion 5.2. Table 2 shows the results of the pre-processing and clas-
siﬁcation. Table 3 shows the results of further re-writing.6
6.1.2. Automated generation of ERGO annotations
Multiple approaches to applying NLP to the atomic eligibility
criteria are possible. We tried three different NLP parsers,7,8,9 and
we used theopen-biomedical annotator (OBA) of the National Center
for Biomedical Informatics [8] and NLM’s MMTx to obtain two sets of
results. We describe below the NLP procedures we used in this fea-
sibility study. They serve as examples of how to use NLP techniques
to generate ERGO annotations.
To obtain the ﬁrst set of results, we took the following steps:
(1) Apply OBA to the pre-processed criteria to get the longest
coded string and their UMLS CUIs and semantic types.
(2) Words from the phrases corresponding to CUIs are formed
into single compound words (e.g., if ‘‘postauricular scar” is
a phrase that correspond to some CUI, we will use ‘‘postau-
ricular-scar”).
(3) Run pre-processed criteria through the OpenNLP Parser to
ﬁnd noun phrases in parse trees.
(4) Use the heuristic algorithm described in Section 5.2 to
extract noun phrases and their modiﬁers for simple criteria
and noun phrases, comparison operators, and quantities
for comparison criteria, discarding everything else.
The steps are illustrated in Fig. 4.
To obtain the second set of results, we applied the following
procedure:
(1) Apply MMTx to the pre-processed criteria to get the best
phrase chunking and CUI matches.6 All eligibility criteria of trial NCT00655473 and tables showing how they were
pre-processed and rewritten area available as part of the online appendix.
7 OpenNLP: http://opennlp.sourceforge.net/.
8 Stanford Parser: http://nlp.stanford.edu/software/lex-parser.shtml.
9 Apple Pie Parser: http://nlp.cs.nyu.edu/app/.(2) Apply NpParser (part of the MMTx toolkit) to obtain the
parts of speech of the words in the criterion.
(3) Use the same heuristic algorithm to generate the candidate
ERGO annotations.
The outputs of the semi-automated annotation process are cri-
teria with their acquired ERGO annotations. For example, OBA rec-
ognized ‘‘heart failure” in ‘‘Severe heart failure” as a UMLS term,
and the OpenNLP Parser generated the parse tree [NP Severe/JJ
heart-failure/NN]. Our heuristic algorithm, in this case, used the
noun (NN) as the root noun phrase and the adjective (JJ) as the
modiﬁer in the acquired ERGO annotation for the criterion.6.2. Examples of use
To demonstrate applicability of OWL-based ERGO annotations
to our use cases, we deﬁned an OWL ontology (Fig. 5) that consists
of a Study class with a property called has_eligibility_criteria that is
specialized into has_exclusion_criteria and has_inclusion_criteria
subproperties. The Criterion class has a property called
has_ERGO_annotation. ERGO annotation may be a Noun_phrase_
type or a Comparison_Annotation. Noun_phrase_type has subclasses:
demographic, disease, and other UMLS semantic types. Compari-
son_Annotation has object properties has_noun_ phrase and
has_quantity, and the Quantity class has a ﬂoat value and unit.
When the quantity part of a comparison annotation is a string, it
plays no part in the OWL formalization of ERGO annotation. ERGO
annotations for complex statements are written as OWL expres-
sions involving noun phrase type and comparison annotation.
We illustrate the application of ERGO annotations to our uses
cases by annotating three studies from ClinicalTrials.gov: NCT
00655538, NCT 00655473, and NCT 00799903. The ﬁrst two have
the inclusion criterion ‘‘adult patients, 18–75 years of age” and
the exclusion criterion ‘‘poorly controlled diabetes.” The third has
the inclusion criterion ‘‘age >= 18 years.”
For ‘‘poorly controlled diabetes,” the valid ERGO annotations are
(a) C0011849 (Diabetes_Mellitus), (b) C0743131 (Uncon-
trolled_Diabetes), and (c) C0011849 (Diabetes_Mellitus)
modiﬁed by C0205318 (Uncontrolled). We can write a necessary
and sufﬁcient deﬁnition of Uncontrolled_Diabetes as Diabe-
tes_Mellitus and (some attribute Uncontrolled). The
annotation for ‘‘age > 18” is formalized as a comparison annotation
‘‘has_noun_phrase some Age and has_quantity some (Quan-
tity and has_value some float [>18] and has_unit value
year), where year is an individual of the unit class.
Examining our ﬁrst use case, investigators interested in using
standard eligibility criteria for their study protocols may search
for ‘‘Diabetes Mellitus” and retrieve all three ERGO annotations
and their associated eligibility criteria. They will see that ‘‘Diabetes
Mellitus” is more general than the others.
A query such as (Study and exclusion_criteria some
(Criterion and has_ergo_annotation some Diabetes_
Mellitus)) will return studies with an exclusion criterion that in-
cludes any subclass of Diabetes_Mellitus (e.g., NCT 00655538, NCT
00655473). A query Study and inclusion_criteria some
(Criterion and has_ergo_annotation some (Compari-
Table 3
Selected eligibility criteria after re-writing and splitting into atomic elements.
After re-writing Atom1 Atom2 Atom3
Adult DEFINED_BY (age >= 18 years
AND age <= 75 years)
Adult Age >= 18 years Age <= 75 years
Coronary heart disease OR coronary
heart disease risk factors
Coronary heart disease Coronary heart disease
risk factors
Previous exposure to any cholesteryl-ester
transfer protein inhibitor OR previous
exposure to any cholesteryl-ester transfer
protein vaccine
Previous exposure to any
cholesteryl-ester transfer
protein inhibitor
Previous exposure to any
cholesteryl-ester transfer
protein vaccine
Poorly controlled diabetes [no change] Poorly controlled diabetes
Fig. 4. Steps in automated generation of ERGO annotations.
Figure 5. Predeﬁned OWL ontology to illustrate how ERGO annotations may be
used to classify criteria and to search for.
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float [>16.0]) and has_noun_phrase some Age)) will return
studies with inclusion criteria more restrictive than age > 16
(including all three studies discussed here).
Use case 3 involves querying a database of patient information
to screen for potentially eligible patients. We exemplify our ap-
proach of translating an ERGO annotation into an SQL query using
the criterion ‘‘CHD OR CHD risk equivalent.” In order to match pa-
tient data that correspond to ‘‘CHD risk equivalent,” this criterion
was ﬁrst rewritten as two statements: ‘‘CHD or Diabetes mellitus
or carotid artery disease or peripheral vascular disease or abdom-
inal aortic aneurysm” and ‘‘Framingham coronary heart disease
10 year risk score > 0.2.” This rewrite illustrates the fact thathigh-level terms in eligibility criteria (e.g., CHD risk equivalent) of-
ten need to be expressed in more concrete terms in order to match
them against patient data. The corresponding ERGO annotations
are shown in Fig. 2.
Following the methods for converting an ERGO annotation for a
simple statement with an AndOr_Noun_Phrase into an SQL query,
we obtain the following query corresponding to Fig. 2a:
 SELECT * FROM ProblemList, TerminologyMapping
 WHERE (problem_code = EHR_code and UMLS_code= ”C0010
068”) or
 (problem_code = EHR_code and UMLS_code = ”C0162871”)
or
 (problem_code = EHR_code and UMLS_code = ”C0011849”)
or
 (problem_code = EHR_code and UMLS_code = ”C0018802”)
or
 (problem_code = EHR_code and UMLS_code = ”C0085096”);
7. Preliminary evaluations
7.1. Ability of ERGO annotations to capture the semantics of common
eligibility criteria
We assessed the extent to which ERGO annotations can capture
the semantics of real-life eligibility criteria. For this evaluation, we
used the study on eligibility criteria complexity described above
[12], and speciﬁcally the 637 criteria in this study that were infor-
mative. Of these, 125 (20%) are elementary criteria whose seman-
tics can be fully captured by ERGO annotation. ERGO annotation is
unable to fully express temporal connectors and temporal compar-
ison operators (present in 38% of the informative criteria in this
sample), but can nevertheless capture some useful information.
For example, annotating the criterion ‘‘chemotherapy treatment
248 S.W. Tu et al. / Journal of Biomedical Informatics 44 (2011) 239–250after surgery” with a conjunction of ‘‘chemotherapy” and ‘‘surgery”
still captures some of the requirements speciﬁed in the criterion.
Instead of omitting criteria that include temporal connectors and
comparison operators, annotating them with ERGO annotations
that partially capture their semantics will help increase the overall
accuracy of applying the criteria in the use cases. This analysis
gives us a rough lower and upper bounds (20% and 62%) on the
proportion of informative criteria whose semantics ERGO annota-
tion can fully capture. Fortunately, as we will describe in the Dis-
cussion, the utility of ERGO annotations does not depend on the
annotations expressing the full meaning of the eligibility criteria.
Using ERGO annotations that capture partial meaning of the crite-
ria will affect the recall and precision of the query results, but for
many purposes (e.g., screening a large database to ﬁnd subjects
who are potentially eligible for a study or identifying studies focus-
ing on particular diseases), the queries may be sufﬁciently general-
ized so that ERGO annotations could be functionally adequate.
ERGO annotations could potentially fully specify the meaning of
all non-temporal informative eligibility criteria (61%, including the
25% that are elementary criteria). Therefore, ERGO can fully specify
25–61% of the informative criteria and could partially represent the
meaning of the rest.7.2. Performance of automated encoding process
For our initial feasibility study, we evaluated our NLP tools by
comparing their noun phrase outputs against the manually derived
ERGO annotation for each test criterion. The manual standard is the
most speciﬁc noun phrase as discussed in Section 5.1. An exact
match occurs when the noun phrase output is a valid ERGO anno-
tation exactly matching or semantically equivalent to the manual
standard. A match is when the output is a valid ERGO annotation
but not semantically equivalent to the manual standard (e.g., the
output is ‘‘Asthma” when the manual standard is ‘‘Severe Asth-
ma”). In this case, for simple statements, a match is a generaliza-
tion of the manual standard, and is at least as speciﬁc as the root
noun in the statement. Similarly, a match for a complex statement
is always a generalization of the manual standard. A non-match is
when the output is not a valid ERGO annotation of the manual
standard. For a comparison criterion, an exact match requires that
the acquired annotation include not only the maximally speciﬁc
noun phrase but also the comparison operator and the quantity
components.
We constructed our test set of criteria by searching ClinicalTri-
als.gov with ‘‘heart disease” on January 12, 2009 and selecting the
second, sixth, eighth, and tenth open interventional studies. (Trial
#2 and #4 had several criteria in common, so we excluded #4.) The
four trials yielded 60 distinct criteria, of which we removed six be-
cause they were too vague or non-discriminating. After re-writing,
the criteria were decomposed into unique 100 simple and 13 com-
parison statements, yielding 113 atomic statements.
We manually annotated the atomic statements (Table 4) to gen-
erate the reference set of ERGO annotations. We then applied ourTable 4
Manually annotating the criteria with the maximally speciﬁc ERGO annotations.
Atom
Adult
Age >= 18 years
Age <= 75 years
Coronary heart disease
Coronary heart disease risk factors
Previous exposure to any cholesteryl-ester transfer protein inhibitor
Previous exposure to any cholesteryl-ester transfer protein vaccine
Poorly controlled diabetesautomated method for generate ERGO annotations to the atomic
statements and manually compared the output to the reference
standard. Using the ﬁrst procedure described in Section 6.1, we ob-
tained 54 (47.8%) exact matches, 22 (19.5%) matches, and 37
(32.7%) non-matches. Using the second procedure described in
Section 6.1, we obtained 68 (60%) exact matches, 6 (5%) matches,
and 39 (35%) non-matches. Most of the new exact matches were
the result of special code written to improve the recognition of
comparison criteria. MMTx and the combination of OBA/OpenNLP
gave us roughly similar results.8. Discussion
ERGO annotation changes the problem of representing eligibil-
ity criteria from formal encoding in some expression language to
classifying and decomposing criteria and identifying noun phrases
in simple and comparison criteria. Our prior study of 1000 ran-
domly selected eligibility criteria and the ERGO expression lan-
guage inform the categorization and decomposition of criteria
into simple and comparison criteria connected by Boolean and
other semantic connectors. ERGO annotation aims to capture the
basic semantics of criteria by identifying linguistic noun phrases
and formalizing them as terminological expressions, in place of de-
tailed modeling based on some information model.
Our attempts to use OWL and a relational database to solve the
three use cases described above clariﬁed the roles that each tech-
nology can play in each use case. We formulated the ﬁrst two
use cases – searching for an eligibility criterion in a classiﬁcation
hierarchy, and searching for studies whose eligibility criteria sat-
isfy a conjunction of criteria – as classiﬁcation problems that are
best solved using description logic technology, as we illustrated
using OWL queries. We showed an easily implementable user
interface that a clinician with some training in the use of terminol-
ogies can potentially utilize to formulate queries to search for stud-
ies that satisfy fairly complex criteria.
The third use case – screening a database of patient information
to ﬁnd potentially eligible subjects – is best done with a conven-
tional technology like relational databases. We illustrated how
ERGO annotations can be turned into SQL queries, after making
certain assumptions about the patient information model and ter-
minology. As in guideline-based decision support systems (DSS),
there is no way to avoid this step if your task is to match abstract
criteria to concrete patient data. This type of matching has been
done before in DSS that derive their data from EHRs. Tools are
available to support the mapping process [18,19]. For example,
KDOM [18] can map terms in criteria to terms in an EHR by going
through an intermediate global-as-view schema such as the HL7
RIM virtual medical record [20] or the simple data model that we
used here to generate SQL queries, like those illustrated in Section
6.2.
For a given criterion classiﬁed as ‘‘simple” in our categorization,
the ERGO annotation is always more generic than the criterion’s in-
tended meaning, simply because there are aspects of criteria, suchERGO annotations
Adult [NP]
Age [NP], >=, 18 years
Age [NP], <=, 75 years
Coronary [modiﬁer] heart disease [NP]
Coronary [modiﬁer] heart disease [modiﬁer] risk factors [NP]
Previous [modiﬁer] exposure to cholesteryl-ester transfer protein inhibitor [NP]
Previous [modiﬁer] exposure to cholesteryl-ester transfer protein vaccine [NP]
Poorly controlled [modiﬁer] diabetes [NP]
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dures, that are not captured in ERGO annotations. For example, a
criterion such as ‘‘Asthma within last 6 months” will be annotated
with ‘‘Asthma” (UMLS CUI C0004096). If the criterion is an inclu-
sion criterion, the use of formalized ERGO annotation (as an OWL
or SQL expression) to resolve queries for studies or to screen eligi-
ble patients introduces the possibility of false positives and thus
decreases the precision of ERGO annotations. On the other hand,
when a concept is negated or when a criterion is used as an exclu-
sion criterion, ERGO annotations become too restrictive and have
the effect of introducing false negatives. In this case the use of
ERGO annotation may decrease the recall of queries. We attempt
to minimize such problems by deﬁning the notion of a preferred
ERGO annotation for a criterion, one that minimizes both false pos-
itives (by taking the most speciﬁc annotation for a positive concept
or inclusion criterion) and false negatives (by taking the least spe-
ciﬁc annotation for a negated or exclusion criterion).
If we ignore the modiﬁers and semantic connectors, ERGO
annotations collapse into Boolean combinations of terminology
codes that are more generic than ERGO annotations with modiﬁers.
For the use case of screening subjects for studies, using such termi-
nology codes for inclusion criteria has the effect of introducing
additional false positives. For negated concepts and exclusion cri-
teria, using only terminology codes introduces additional false neg-
atives. For the use case of querying for studies, the terminological
expressions that index studies and allow formulation of queries are
Boolean combinations of terminology codes. A simpler reasoner
than a full-strength description-logic reasoner can resolve such
queries. If we take the automated matches and exact matches from
our feasibility study as the ERGO annotations to use in indexing eli-
gibility criteria and studies, we obtain a system that is intermedi-
ate between the full ERGO annotation system and the simpliﬁed
system described here.
The advantages of ERGO annotation over formal expression lan-
guages like Arden Syntax [6] or GELLO [7] are twofold: the scalabil-
ity of its annotation process, and the possibility of reasoning about
eligibility criteria. Annotating eligibility criteria is much more scal-
able because no knowledge of arcane syntax is required, and anno-
tators can be assisted by automated tools to detect noun phrases
and recognize terms from standard vocabularies. Any formaliza-
tion of natural language clinical text into a computable representa-
tion necessarily involves decomposition of complex linguistic
phrases into stylized expressions. This decomposition requires
some clinical and linguistic knowledge as well as an understanding
of formal languages and terminologies. The type of pre-processing
described in Section 5.2 is needed regardless of the chosen target
representation, be it GELLO, Arden Syntax, or ERGO annotation.
The training required for using ERGO annotation is less than for
using other expression languages because an ERGO annotator does
not have to know the details of patient data representation and the
syntax of the expression language. Instead, she only needs to focus
on the principal noun phrases in the eligibility criteria, to ﬁnd
appropriate terminological codes for the concepts and relation-
ships, and to construct annotations for complex statements using
the rules described in this paper. For the criterion ‘‘Presence of azo-
temia within the last 3 months,” instead of writing expressions
shown in Fig. 1, she only has to annotate the criterion with the ter-
minology code for ‘‘azotemia.”
ERGO annotation does trade expressiveness for the scalability of
the annotation process. For example, at current time, ERGO anno-
tations do not capture temporal requirements that an eligibility
criterion may impose on a medical condition or therapy (e.g.,
‘‘Presence of azotemia within the last 3 months”). On the other
hand, criteria encoded in Arden Syntax or GELLO are of no use
for our ﬁrst two use cases. Searching for eligibility criteria or forstudies that target a patient cohort deﬁned by a set of criteria
requires (1) a way to index and classify the eligibility criteria,
and (2) a reasoner that can resolve queries by checking subsump-
tion relationships between the query expression and the eligibility
expressions that index the studies. Expression languages like Ar-
den Syntax and GELLO are not designed for these tasks.
ERGO annotations expressed as OWL expressions can comple-
ment ASPIRE’s sets of standardized eligibility codes by giving them
an ontological foundation. Instead of needing to enumerate stan-
dard codes such as ‘‘Breast Cancer Estrogen-Receptor Status (Posi-
tive/Negative/Unknown)”, we can associate criteria codes with
their corresponding ERGO annotations organized in a classiﬁcation
hierarchy, making semantic relationships among the codes
explicit.
At a basic level, our work may contribute to reducing the
variability of eligibility criteria texts. Recall that a full 36% of the
criteria in our sample of 1000 from ClinicalTrials.gov were incom-
prehensible or ‘‘underspeciﬁed.” Variant criteria such as ‘‘treated
appropriately for dyslipidemia” and ‘‘Current treatment with statin
therapy unless the study doctor determines statins are not appro-
priate for the subject” in the context of heart failure trials may in
fact target similar subjects. The rewrite rules developed for this
project can help study authors write eligibility criteria more clearly
and uniformly. A standard library of eligibility criteria can reduce
unnecessary variability in the target populations of studies, thus
making study results more comparable.
9. Limitations
One limitation of our method is that we have not modeled the
temporal aspects of eligibility criteria. A large proportion of the eli-
gibility criteria surveyed in our study have some kind of temporal
constraint or comparison (Table 1). Our current work will extend
the ERGO annotation formalism to include temporal comparisons
of the form (Noun_phrase1 temporal comparison operator Noun_-
phrase2). We will interpret Noun_phrase1 and Noun_phrase2 as
representing sets of events that have associated time stamps. A
temporal comparison like (radiation therapy before chemother-
apy) means the presence of some radiation therapy whose associ-
ated time stamp is before that of some chemotherapy a patient has
received. We are currently exploring the logical implications of this
extension. It does not capture all types of temporal constraints and
comparisons we see in eligibility criteria, but is a ﬁrst step in a rich
research direction.
Compared to the state of art in identifying maximal noun
phrases in radiology reports, where the recall rate can be 82% or
higher [11], our best recall rate (counting both exact matches
and matches) of 67% shows relatively low recall at generating cor-
rect ERGO annotations. This is not surprising, given the preliminary
NLP techniques used in this early work whose objective was to
demonstrate the feasibility of automating this part of the annota-
tion process. Using MeLEE [11] without any initial training, Bor-
lawsky and Payne obtained similar results (14% of the criteria
completely and correctly parsed and 62% partial parses) [21]. Much
can be done to improve the recognition rate of the tools. For exam-
ple, the statistical NLP parsers can be trained on eligibility text.
Furthermore, we will evaluate the use of advanced biomedical
NLP tools such as ChartIndex [12].
The evaluation described in Section 7.2 is limited by the lack of
a true gold standard for ERGO annotations of eligibility criteria.
Ideally, the noun phrases, modiﬁers, and semantic connectors that
constitute ERGO annotations should come from controlled termi-
nologies that have been harmonized to provide consistent seman-
tics. Individuals not involved in the development of ERGO
annotations should establish the reference annotations, and
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ment of automated methods. The reference ERGO annotations
manually created for the feasibility study do not require terms
from controlled vocabularies to be found for all primitive noun
phrases. The semantic connectors (e.g., ‘‘evidenced by” and ‘‘caused
by”) that link clinical statements and terminological modiﬁers that
reﬁne noun phrases represent relationships that should be stan-
dardized if we are to have a rich compositional language for
expressing clinical concepts and statements. Several groups have
adopted their own sets of standard relationships. HL7 uses a collec-
tion of Act Relationships (e.g., ‘‘has component” and ‘‘has reason”)
that plays exactly the same role as our semantic connectors [22].
SNOMED CT has a standard set of qualiﬁers, such as severity and
ﬁnding site, for post-coordinating terms [23]. The open biomedical
ontology foundry has proposed a relations ontology for biomedi-
cine [24]. None of these efforts, however, are coordinated or ma-
ture enough for the purpose of encoding eligibility criteria in a
standard way.
In our preliminary evaluation, we mapped recognized entities
into UMLS CUIs because of UMLS’s comprehensive coverage of
biomedical terms and because existing NLP tools use UMLS as
the default source of terminology. Our use cases, however, require
us to evaluate subsumption relationships among different terms
and possibly compositional terms. UMLS CUIs themselves are
not organized along subsumption relationships. The ‘‘broader”
and ‘‘narrower” relations only give broader and narrower con-
cepts in speciﬁc terminologies. To properly manage subsumption
relationships among ERGO annotations, ideally the terms and
relationships in eligibility criteria should be mapped to reference
terminologies, like SNOMED CT, that guarantee appropriate sub-
sumption classiﬁcation of terms and that provide the mechanism
to post-coordinate new terms from primitive terms and their
modiﬁers.
Ultimately, ERGO annotations will be judged by their utility in
satisfying use cases that clinicians and biomedical investigators
ﬁnd important. A formal evaluation of ERGO annotation requires
(1) that we annotate a large number of studies with ERGO annota-
tions, (2) that we demonstrate the ability of a clinician or investi-
gator to query for studies with better recall and precision than
using existing methods, and (3) that we show the use of ERGO
annotation facilitates screening potentially eligible study subjects.
The scope of our project does not permit us to perform such an
evaluation. Nevertheless, if the eligibility criteria of a large collec-
tion of studies can be annotated cheaply and consistently using
manual or automated methods, the computational tractability of
ERGO annotations for the three use cases discussed in the paper
(Section 5.3) will prove this approach worthy.
10. Conclusion
We deﬁned a formal representation called ERGO annotation for
annotating eligibility criteria and demonstrated the capture of eli-
gibility semantics that supports queries of sufﬁcient richness to en-
able three important use cases in clinical research: classifying an
eligibility criterion in a library of criteria; ﬁnding studies that use
particular criteria; and identifying patients who are potentially eli-
gible for a study. The ERGO annotation representation requires no
knowledge of complex expression languages. We have tested the
feasibility of using a semi-automated approach for transforming
text-based eligibility criteria into the formal representation. ERGO
annotation and our semi-automated approach provide an expres-
sive ontological and methodological foundation for computable
representations of eligibility criteria.Acknowledgments
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